DALBAVANCIN HYDROCHLORIDE

DALBAVANCIN HYDROCHLORIDE was reported 474 times

DALBAVANCIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALCOHOL INDUCED PERSISTING DEMENTIA 1 0.0417
1 PELVIC HAEMORRHAGE 5 0.0228
2 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 1 0.0145
3 VANCOMYCIN INFUSION REACTION 5 0.0133
4 COAGULATION TIME ABNORMAL 3 0.0100
5 HYPOPARATHYROIDISM SECONDARY 1 0.0086
6 APPLICATION SITE NODULE 1 0.0073
7 MYELOMA CAST NEPHROPATHY 1 0.0070
8 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6 0.0067
9 PARASPINAL ABSCESS 1 0.0065
10 CARCINOMA IN SITU 1 0.0060
11 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
12 JEJUNOSTOMY 1 0.0055
13 STAPHYLOCOCCAL OSTEOMYELITIS 1 0.0054
14 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
15 HEAD AND NECK CANCER 3 0.0044
16 POST PROCEDURAL FEVER 1 0.0041
17 INCISION SITE ABSCESS 1 0.0038
18 EYE HAEMATOMA 1 0.0038
19 OSTEOMYELITIS BACTERIAL 1 0.0036
20 PALPABLE PURPURA 1 0.0036
21 VULVOVAGINITIS 1 0.0034
22 HYPOPROTHROMBINAEMIA 1 0.0033
23 VULVITIS 1 0.0030
24 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
25 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
26 ABSCESS RUPTURE 1 0.0027
27 UREAPLASMA INFECTION 1 0.0025
28 NEUTRALISING ANTIBODIES POSITIVE 1 0.0024
29 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
30 HYPERFERRITINAEMIA 1 0.0023
31 CERVICITIS 1 0.0022
32 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
33 CROSS SENSITIVITY REACTION 2 0.0021
34 CORYNEBACTERIUM INFECTION 1 0.0019
35 OSTEOMYELITIS ACUTE 1 0.0018
36 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
37 DERMO-HYPODERMITIS 1 0.0017
38 MIXED LIVER INJURY 5 0.0017
39 OTOTOXICITY 3 0.0016
40 LARYNGEAL DISCOMFORT 1 0.0016
41 BICYTOPENIA 3 0.0015
42 DEAFNESS NEUROSENSORY 5 0.0015
43 EOSINOPHIL COUNT ABNORMAL 1 0.0013
44 DEBRIDEMENT 1 0.0013
45 MYELITIS 2 0.0013
46 MULTIPLE-DRUG RESISTANCE 4 0.0013
47 BLISTER INFECTED 1 0.0013
48 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
49 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
50 ENDOCARDITIS 6 0.0012
51 ENTEROCUTANEOUS FISTULA 1 0.0011
52 ARTHRITIS INFECTIVE 5 0.0011
53 TONGUE INJURY 1 0.0011
54 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
55 OROPHARYNGEAL SWELLING 1 0.0010
56 PATHOGEN RESISTANCE 9 0.0010
57 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
58 PROSTATIC OPERATION 1 0.0008
59 EOSINOPHILIA 14 0.0008
60 SUDDEN DEATH 8 0.0008
61 ANAPHYLACTOID REACTION 3 0.0007
62 INFUSION SITE RASH 1 0.0007
63 SUDDEN ONSET OF SLEEP 1 0.0007
64 HYPERTRANSAMINASAEMIA 5 0.0007
65 ABSCESS LIMB 3 0.0007
66 VASCULAR INJURY 1 0.0007
67 NORMOCYTIC ANAEMIA 1 0.0007
68 NEPHRECTOMY 1 0.0007
69 PNEUMONIA PSEUDOMONAL 1 0.0007
70 RENAL TUBULAR NECROSIS 6 0.0006
71 PRODUCT PREPARATION ISSUE 4 0.0006
72 ILLUSION 1 0.0006
73 SYSTEMIC INFECTION 1 0.0006
74 BLOOD CREATININE ABNORMAL 2 0.0006
75 CHOLESTASIS 11 0.0006
76 PNEUMONIA KLEBSIELLA 1 0.0005
77 BODY TEMPERATURE ABNORMAL 1 0.0005
78 MECHANICAL VENTILATION 1 0.0005
79 HYPERTRIGLYCERIDAEMIA 3 0.0005
80 HYPERAEMIA 1 0.0005
81 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
82 EMPYEMA 1 0.0005
83 OESOPHAGEAL CANDIDIASIS 2 0.0005
84 DEVICE RELATED SEPSIS 1 0.0005
85 FOAMING AT MOUTH 1 0.0005
86 HEPATOCELLULAR INJURY 7 0.0005
87 EXTRAVASATION 2 0.0005
88 INSULIN RESISTANCE 1 0.0005
89 HYPERPYREXIA 2 0.0005
90 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
91 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
92 CEREBELLAR SYNDROME 1 0.0005
93 BLOOD CREATINE INCREASED 2 0.0005
94 PANCREATITIS CHRONIC 1 0.0004
95 BACTERAEMIA 5 0.0004
96 HAEMATOTOXICITY 4 0.0004
97 WEIGHT ABNORMAL 1 0.0004
98 PULSE ABNORMAL 1 0.0004
99 RASH MACULO-PAPULAR 9 0.0004
100 SUFFOCATION FEELING 1 0.0004
101 GASTROINTESTINAL TUBE INSERTION 1 0.0004
102 TOXIC SKIN ERUPTION 4 0.0004
103 VASODILATATION 1 0.0004
104 HEPATIC CYTOLYSIS 5 0.0004
105 HEPATOSPLENOMEGALY 1 0.0004
106 MEAN CELL VOLUME INCREASED 1 0.0004
107 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
108 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
109 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
110 PRESYNCOPE 9 0.0004
111 PALLOR 10 0.0004
112 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
113 STREPTOCOCCAL INFECTION 2 0.0004
114 HEPATOTOXICITY 8 0.0004
115 LUNG CONSOLIDATION 1 0.0004
116 NEUTROPHIL COUNT ABNORMAL 1 0.0004
117 DRUG RESISTANCE 9 0.0004
118 PHARYNGEAL DISORDER 1 0.0003
119 ESCHERICHIA SEPSIS 1 0.0003
120 AGRANULOCYTOSIS 6 0.0003
121 PHARYNGEAL SWELLING 3 0.0003
122 WOUND DEHISCENCE 1 0.0003
123 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
124 INFUSION RELATED REACTION 19 0.0003
125 EAR PRURITUS 1 0.0003
126 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
127 CUTANEOUS VASCULITIS 1 0.0003
128 THROMBOCYTOSIS 1 0.0003
129 ALCOHOL USE 1 0.0003
130 ACUTE RESPIRATORY FAILURE 5 0.0003
131 TORSADE DE POINTES 2 0.0003
132 EXPOSURE VIA BREAST MILK 1 0.0003
133 HYPERPHAGIA 1 0.0003
134 POST PROCEDURAL INFECTION 2 0.0002
135 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
136 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
137 PURULENT DISCHARGE 1 0.0002
138 ACUTE KIDNEY INJURY 35 0.0002
139 ABDOMINAL ABSCESS 1 0.0002
140 SUSPECTED OFF LABEL USE 1 0.0002
141 VASCULAR DEVICE INFECTION 1 0.0002
142 VAGINAL INFECTION 1 0.0002
143 STAPHYLOCOCCAL INFECTION 7 0.0002
144 BRONCHOSPASM 3 0.0002
145 NON-SMALL CELL LUNG CANCER 1 0.0002
146 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
147 INFLAMMATORY MARKER INCREASED 1 0.0002
148 DRUG TOLERANCE 1 0.0002
149 PRODUCT COLOUR ISSUE 1 0.0002
150 BLOOD LACTIC ACID INCREASED 1 0.0002
151 POLYARTHRITIS 1 0.0002
152 ANORECTAL DISCOMFORT 1 0.0002
153 INTESTINAL RESECTION 1 0.0002
154 NORMAL NEWBORN 1 0.0002
155 JAW DISORDER 1 0.0002
156 CHOKING SENSATION 1 0.0002
157 HYPERTENSIVE CRISIS 2 0.0002
158 ACUTE PULMONARY OEDEMA 1 0.0002
159 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
160 SKIN TOXICITY 1 0.0002
161 CARDIAC VALVE DISEASE 1 0.0002
162 HYPERVENTILATION 1 0.0002
163 METABOLIC DISORDER 1 0.0002
164 COLD SWEAT 3 0.0002
165 DRUG ERUPTION 3 0.0002
166 ATAXIA 2 0.0002
167 INJECTION SITE EXTRAVASATION 2 0.0002
168 INFUSION SITE EXTRAVASATION 1 0.0002
169 LEUKOPENIA 8 0.0002
170 CELLULITIS 8 0.0002
171 HERPES SIMPLEX 1 0.0002
172 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
173 HYPOGAMMAGLOBULINAEMIA 1 0.0002
174 POSTOPERATIVE WOUND INFECTION 1 0.0001
175 HYPOMAGNESAEMIA 2 0.0001
176 SKIN REACTION 2 0.0001
177 PAPULE 1 0.0001
178 PULMONARY TOXICITY 1 0.0001
179 SINUS TACHYCARDIA 2 0.0001
180 LIVER FUNCTION TEST INCREASED 3 0.0001
181 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
182 STEVENS-JOHNSON SYNDROME 3 0.0001
183 HAEMODYNAMIC INSTABILITY 1 0.0001
184 DEVICE RELATED INFECTION 2 0.0001
185 CHILLS 15 0.0001
186 CYANOSIS 2 0.0001
187 ANAPHYLACTIC REACTION 7 0.0001
188 RENAL CYST 1 0.0001
189 ABSCESS 2 0.0001
190 TACHYCARDIA 11 0.0001
191 OSTEONECROSIS OF JAW 3 0.0001
192 EMBOLISM 1 0.0001
193 HAEMODIALYSIS 1 0.0001
194 SKIN PLAQUE 1 0.0001
195 NEUTROPENIA 16 0.0001
196 HEPATITIS 3 0.0001
197 PSEUDOMONAS INFECTION 1 0.0001
198 ANAPHYLACTIC SHOCK 3 0.0001
199 HYSTERECTOMY 1 0.0001
200 SKIN SWELLING 1 0.0001
201 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
202 GROIN PAIN 1 0.0001
203 PURPURA 1 0.0001
204 RESPIRATORY RATE INCREASED 1 0.0001
205 ANAL INCONTINENCE 1 0.0001
206 OROPHARYNGEAL DISCOMFORT 1 0.0001
207 HIDRADENITIS 1 0.0001
208 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
209 HEPATIC ENCEPHALOPATHY 1 0.0001
210 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
211 FLANK PAIN 1 0.0001
212 SQUAMOUS CELL CARCINOMA 1 0.0001
213 LIGAMENT SPRAIN 1 0.0001
214 VAGINAL DISCHARGE 1 0.0001
215 HYPOTHERMIA 1 0.0001
216 PYREXIA 34 0.0001
217 NEUTROPHIL COUNT INCREASED 1 0.0001
218 EAR DISCOMFORT 1 0.0001
219 PETECHIAE 1 0.0001
220 SKIN LACERATION 1 0.0001
221 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
222 ASPIRATION 1 0.0001
223 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
224 TRANSAMINASES INCREASED 2 0.0001
225 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
226 NEPHROPATHY TOXIC 1 0.0001
227 FISTULA 1 0.0001
228 HAEMATURIA 3 0.0001
229 HYPOXIA 3 0.0001
230 TREMOR 14 0.0001
231 POLYNEUROPATHY 1 0.0001
232 TENDON RUPTURE 1 0.0001
233 HYPERCALCAEMIA 1 0.0001
234 THROMBOCYTOPENIA 9 0.0001
235 SECRETION DISCHARGE 1 0.0001
236 HAEMATEMESIS 2 0.0001
237 SEIZURE 9 0.0001
238 ERYTHEMA 16 0.0001
239 INFUSION SITE PAIN 1 0.0001
240 INFLAMMATION 4 0.0001
241 QUALITY OF LIFE DECREASED 1 0.0001
242 THROAT TIGHTNESS 2 0.0001
243 RASH PRURITIC 4 0.0001
244 TACHYPNOEA 1 0.0001
245 DECREASED APPETITE 17 0.0001
246 ACUTE HEPATIC FAILURE 1 0.0001
247 SKIN LESION 2 0.0001
248 CARDIAC ARREST 6 0.0001
249 VOMITING 34 0.0001
250 RHABDOMYOLYSIS 3 0.0001
251 FEELING COLD 2 0.0001
252 HAEMOPTYSIS 2 0.0001
253 RECTAL HAEMORRHAGE 3 0.0001
254 FLUSHING 7 0.0001
255 ANGIOEDEMA 3 0.0001
256 INSURANCE ISSUE 1 0.0001
257 SWOLLEN TONGUE 2 0.0001
258 PNEUMOTHORAX 1 0.0001
259 RESPIRATORY TRACT CONGESTION 1 0.0001
260 PREMATURE DELIVERY 1 0.0001
261 RASH ERYTHEMATOUS 3 0.0001
262 LACTIC ACIDOSIS 2 0.0001
263 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
264 TREATMENT FAILURE 5 0.0001
265 FACE OEDEMA 1 0.0001
266 CHEST DISCOMFORT 6 0.0001
267 THERAPY CESSATION 3 0.0001
268 AMENORRHOEA 1 0.0001
269 HYPERTENSION 12 0.0001
270 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
271 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
272 LEUKOCYTOSIS 1 0.0001
273 END STAGE RENAL DISEASE 1 0.0001
274 HEPATIC STEATOSIS 1 0.0001
275 HYPONATRAEMIA 3 0.0001
276 HYPOCALCAEMIA 1 0.0001
277 FOOT FRACTURE 1 0.0001
278 RENAL FAILURE 7 0.0001
279 OFF LABEL USE 45 0.0001
280 CHOKING 1 0.0001
281 CYTOKINE RELEASE SYNDROME 1 0.0000
282 PRODUCT PHYSICAL ISSUE 1 0.0000
283 PRODUCT ADMINISTRATION ERROR 1 0.0000
284 DISCOMFORT 3 0.0000
285 PRODUCT PREPARATION ERROR 1 0.0000
286 URTICARIA 8 0.0000
287 RENAL IMPAIRMENT 4 0.0000
288 BACK PAIN 11 0.0000
289 RETCHING 1 0.0000
290 LOSS OF CONSCIOUSNESS 6 0.0000
291 PRURITUS GENERALISED 1 0.0000
292 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
293 CONDITION AGGRAVATED 14 0.0000
294 BLOOD CREATININE INCREASED 3 0.0000
295 RASH PAPULAR 1 0.0000
296 SHOCK 1 0.0000
297 HYPOKALAEMIA 2 0.0000
298 MALAISE 18 0.0000
299 LIVER INJURY 1 0.0000
300 PNEUMONIA ASPIRATION 1 0.0000
301 HYPOTENSION 8 0.0000
302 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
303 ERECTILE DYSFUNCTION 1 0.0000
304 HAEMATOMA 1 0.0000
305 DIPLOPIA 1 0.0000
306 DEAFNESS 1 0.0000
307 SEDATION 1 0.0000
308 APPLICATION SITE ERYTHEMA 1 0.0000
309 PANCREATITIS 2 0.0000
310 CHEST PAIN 7 0.0000
311 EAR INFECTION 1 0.0000
312 BLOOD BILIRUBIN INCREASED 1 0.0000
313 RESPIRATORY ARREST 1 0.0000
314 RESPIRATORY DISTRESS 1 0.0000
315 SEPSIS 4 0.0000
316 PANCYTOPENIA 2 0.0000
317 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
318 RED BLOOD CELL COUNT DECREASED 1 0.0000
319 ANGINA PECTORIS 1 0.0000
320 NEEDLE ISSUE 1 0.0000
321 BONE PAIN 2 0.0000
322 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
323 LABORATORY TEST ABNORMAL 1 0.0000
324 PRURITUS 13 0.0000
325 URINARY INCONTINENCE 1 0.0000
326 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
327 ADVERSE DRUG REACTION 3 0.0000
328 FEELING HOT 2 0.0000
329 DRUG ADMINISTRATION ERROR 1 0.0000
330 NERVOUS SYSTEM DISORDER 1 0.0000
331 DRUG-INDUCED LIVER INJURY 1 0.0000
332 ANAEMIA 6 0.0000
333 HYPERHIDROSIS 4 0.0000
334 IMPAIRED HEALING 1 0.0000
335 HEART RATE INCREASED 3 0.0000
336 LIP SWELLING 1 0.0000
337 FUNGAL INFECTION 1 0.0000
338 URINARY RETENTION 1 0.0000
339 RASH 13 0.0000
340 DIARRHOEA 19 0.0000
341 HEPATIC ENZYME INCREASED 2 0.0000
342 DRUG INEFFECTIVE 38 0.0000
343 DELIRIUM 1 0.0000
344 RASH MACULAR 1 0.0000
345 MYELOSUPPRESSION 1 0.0000
346 CRYING 1 0.0000
347 DYSURIA 1 0.0000
348 INJECTION SITE MASS 1 0.0000
349 PLASMA CELL MYELOMA 1 0.0000
350 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
351 THROMBOSIS 2 0.0000
352 DEVICE BREAKAGE 1 0.0000
353 CARDIO-RESPIRATORY ARREST 1 0.0000
354 OSTEOARTHRITIS 1 0.0000
355 PULMONARY OEDEMA 1 0.0000
356 MUSCLE SPASMS 4 0.0000
357 SKIN DISCOLOURATION 1 0.0000
358 HYPERSENSITIVITY 4 0.0000
359 RENAL DISORDER 1 0.0000
360 DYSPNOEA 12 0.0000
361 DISEASE RECURRENCE 1 0.0000
362 DRUG INTOLERANCE 2 0.0000
363 ATRIAL FIBRILLATION 2 0.0000
364 SYNCOPE 2 0.0000
365 AGGRESSION 1 0.0000
366 HAEMOGLOBIN DECREASED 2 0.0000
367 PERIPHERAL SWELLING 3 0.0000
368 ABDOMINAL PAIN UPPER 4 0.0000
369 ECZEMA 1 0.0000
370 NAUSEA 15 0.0000
371 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
372 MEDICATION ERROR 1 0.0000
373 NECK PAIN 1 0.0000
374 BLISTER 1 0.0000
375 WHEEZING 1 0.0000
376 IRRITABILITY 1 0.0000
377 STOMATITIS 1 0.0000
378 VERTIGO 1 0.0000
379 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
380 EXPOSURE DURING PREGNANCY 1 0.0000
381 DEEP VEIN THROMBOSIS 1 0.0000
382 SWELLING FACE 1 0.0000
383 BLOOD PRESSURE DECREASED 1 0.0000
384 DEHYDRATION 2 0.0000
385 INJECTION SITE REACTION 1 0.0000
386 DIZZINESS 7 0.0000
387 INFECTION 2 0.0000
388 UNDERDOSE 1 0.0000
389 PAIN IN EXTREMITY 4 0.0000
390 CHRONIC KIDNEY DISEASE 1 0.0000
391 DIABETES MELLITUS 1 0.0000
392 ABDOMINAL PAIN 3 0.0000
393 ARTHRITIS 1 0.0000
394 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
395 DRY MOUTH 1 0.0000
396 ABDOMINAL DISCOMFORT 2 0.0000
397 SKIN EXFOLIATION 1 0.0000
398 PRODUCT STORAGE ERROR 1 0.0000
399 COVID-19 2 0.0000
400 GASTROINTESTINAL DISORDER 1 0.0000
401 SUICIDAL IDEATION 1 0.0000
402 ADVERSE EVENT 1 0.0000
403 WEIGHT DECREASED 3 0.0000
404 BREAST CANCER 1 0.0000
405 PRODUCT USE ISSUE 2 0.0000
406 PULMONARY EMBOLISM 1 0.0000
407 ALOPECIA 2 0.0000
408 PAIN 6 0.0000
409 HAEMORRHAGE 1 0.0000
410 PLATELET COUNT DECREASED 1 0.0000
411 MUSCULAR WEAKNESS 1 0.0000
412 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
413 JOINT SWELLING 1 0.0000
414 OEDEMA PERIPHERAL 1 0.0000
415 ASTHENIA 3 0.0000
416 PRODUCT QUALITY ISSUE 1 0.0000
417 VISION BLURRED 1 0.0000
418 MEMORY IMPAIRMENT 1 0.0000
419 ARTHRALGIA 3 0.0000
420 COUGH 2 0.0000
421 ANXIETY 2 0.0000
422 DEATH 6 0.0000
423 PRODUCT DOSE OMISSION ISSUE 2 0.0000
424 BLOOD PRESSURE INCREASED 1 0.0000
425 INJECTION SITE PAIN 2 0.0000
426 HOSPITALISATION 1 0.0000
427 DRUG INTERACTION 1 0.0000
428 DRUG DEPENDENCE 1 0.0000
429 CONFUSIONAL STATE 1 0.0000
430 PNEUMONIA 2 0.0000
431 CEREBROVASCULAR ACCIDENT 1 0.0000
432 MYALGIA 1 0.0000
433 URINARY TRACT INFECTION 1 0.0000
434 NO ADVERSE EVENT 1 0.0000
435 NASOPHARYNGITIS 1 0.0000
436 BLOOD GLUCOSE INCREASED 1 0.0000
437 OVERDOSE 1 0.0000
438 WEIGHT INCREASED 1 0.0000
439 FEELING ABNORMAL 1 0.0000
440 FATIGUE 3 0.0000
441 INSOMNIA 1 0.0000
442 FALL 1 0.0000
443 HEADACHE 1 0.0000